Clinical Trial

Glycated Hbg Index and RDW as Prognstic Indicator in Critical Ill Patients

Name: Glycated Hbg Index and RDW as Prognstic Indicator in Critical Ill Patients — clinical trial record (NCT07057154)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The aim of this study was to evaluate the impact of GHI and RDW as prognostic indicator in critically ill Patients.

Trial Details

NCT Number	NCT07057154
Lead Sponsor	Assiut University
Conditions	Critical Ill Patients
Enrollment	97 participants
Start Date	2025-07-05
Primary Completion	2026-08-29 (estimated)
Study Completion	2026-12-02 (estimated)
Updated on ClinicalTrials.gov	2025-07-09